GOSH treats 50th patient with thymus transplant
13 Apr 2021, 1 p.m.
Last month, Great Ormond Street Hospital (GOSH) treated its 50th patient with a pioneering thymus transplant.
GOSH Charity's generous donors have supported the hospital team to reach this milestone.
Dr Kiki Syrad, Director of Grants and Impact at GOSH Charity, said:
“The brilliant team of clinicians and researchers are using charity funding to discover new ways to increase further the number of immune cells produced after the transplant, and to reduce the chances of complications.
"This is exactly the kind of life-changing impact that funding for paediatric research can offer to seriously ill children and their families, and is why funding research remains so important.”
What is a thymus?
The thymus gland produces T-cells, which are white blood cells with a vital role in fighting infections.
Infants born without a thymus are said to have athymia, most commonly due to a rare disorder called complete DiGeorge syndrome (cDGS).
As a result, they lack T-cells and are likely to die within the first two years of life unless the problem can be corrected.
What is this new pioneering treatment?
The technique for this transplant was developed in the United States. It uses healthy thymus tissue removed by surgeons who gain access to the heart during surgery for congenital heart disease in infants. This tissue would otherwise be discarded but with parental consent can be donated for transplantation.
The removal has little effect on the thymus donor as their immune system has already developed and not all the gland is usually removed. The tissue is then grown in the laboratory before implantation into the thigh muscles of the patient with athymia.
It has been reported that around 75 percent of patients with cDGS had a successful outcome after receiving a thymus transplant.
Some patients do develop complications after transplantation. This is as a result of the new T-cells being poorly regulated which can cause some damage to the body’s own tissues. These problems are usually treatable. However, the research team at GOSH are working to optimise the process and reduce the chance of such complications.
The transplantation programme
Following the lockdown in March 2020, the transplantation programme was suspended. This is because some of the team were needed for COVID-related clinical duties.
The programme was later granted special permission from NHS England to resume accepting patients.
Despite the pandemic, the team at GOSH made great progress in 2020. They treated 10 patients, which was double the average number performed in each of the previous three years.
GOSH Charity funds the £1million programme to support GOSH researchers and clinicians to further develop this treatment, which GOSH offers on the NHS.
GOSH is one of two centres in the world to perform such transplants, the other being Duke University in the USA. Patients travel to GOSH from all over Europe and further with one case last year travelling from as far as New Zealand*. Restoring the immune system takes several months and the children remain highly susceptible to infection. They need to be carefully managed by their home medical teams during this time.
Florentina's thymus transplant
GOSH carried out its first thymus transplant in 2009. In March 2021, four-month-old Florentina from Germany became the 50th patient to receive the procedure at GOSH.
While it is too early to measure the long-term success of the transplant, doctors are pleased with Florentina’s progress so far.
Florentina’s mum, Stefanie, said: “The procedure went very well. I think it will take a while to see the positive impact of the transplant - we were told that it will take around eight to nine months for the T cells to develop. In the meantime, we have to be careful with her and make sure she doesn’t get any infections.
“Until we arrived at GOSH, she hadn’t seen me without a mask. This is the first time she’s seeing anyone, including myself without one. I love how I can now properly converse with her.”
Oscar’s thymus transplant
Oscar, from Ammanford in Wales, received his thymus transplant at GOSH in September 2019.
Oscar’s health complications began as soon as he was born in May 2019. Early diagnoses revealed that he had CHARGE syndrome. This is a rare genetic disorder that affects many areas in the body, including the eyes, heart and ear.
The severity of Oscar’s conditions became more apparent when further blood tests revealed that he had an absence of T -cells, which play a central role in the adaptive immune response.
When Oscar was three months old, he was transferred to GOSH for a thymus transplant. The transplant was a success, and despite a few health scares in between – including a cardiac arrest - Oscar is now home for the first time in his life.
Oscar’s mum, Bryony, said: “I can’t fault the thymus transplant team – they were amazing. I never felt that I didn’t know what was going on. They were there for me as well as Oscar.
“Oscar is very complex – he’s deaf and blind in one eye. He’s not crawling or walking yet either, but we hope he will pick that up. I’m also not sure whether speech will be possible in the future, but I always say ‘never say never’ with Oscar.”
This work has been made possible thanks to a grant from LetterOne to support the Letter One/GOSH Charity Research Group in Thymus Transplantation which also receives funding from the Jeffrey Modell Foundation, the Wellcome Trust (to Prof Adrian Thrasher, Principal Research Fellow) and the National Institute of Health Research through the Biomedical Research Centre at GOSH.
*Treatment for international patients is funded by their home governments or by insurance.